Cancer Therapy
Supplemental BLA submitted for Avastin in relapsed metastatic colorectal cancer
Published in Drug Week, January 27th, 2006
Avastin is currently approved as a first-line treatment of metastatic colorectal cancer in combination with intravenous 5-FU-based chemotherapy.
The sBLA submission is based on results of a randomized, controlled, multicenter phase III trial (E3200) of 829 patients with advanced or metastatic colorectal cancer (CRC) whose disease progressed following previous treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-01-27)
More Articles from Drug Week
- Cancer Therapy
Cervical cancer vaccine candidate induced a higher immune response in young girls - Drug Development
High response rates reported in use of single agent Treanda in non-Hodgkin lymphoma - Pain Management
U.S. FDA accepts investigational new drug application for Sativex - Rotavirus
Vaccine candidate shown effective against rotavirus disease in infants - Abortion
Studies evaluate misoprostol use to terminate pregnancies in Latin America - Actinic Keratoses
Diclofenac in 2.5% hyaluronan gel is effective for actinic keratoses - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
